August 31, 2022
Article
Temperatures changes between summer and the rest of the year correlated with the magnitude of decrease in renal function during summer.
August 30, 2022
Increased risk of AF by fish oil supplement was found to be prominent in low risk participants with healthy lifestyles.
August 29, 2022
Full-dose anticoagulation, but not clopidogrel, reduced thrombotic complications in critically-ill patients with COVID-19.
Digital screening more than doubled the detection rate of treatment-relevant AF in both phases of eBRAVE-AF trial.
August 27, 2022
SGLT2 inhibitors reduce the risk of hospitalization for heart failure, extend survival, and improve overall health status, irrespective of ejection fraction, in patients with heart failure.
August 26, 2022
The treatment strategy led to lower risk of major adverse cardiovascular events than usual care in older patients with recent myocardial infarction.
The risk of coronary heart disease and stroke decreased by 22% for every 1 point rise in the sleep score at baseline.
August 31, 2021
Data show the outcome of all-cause mortality, MI, or stent thrombosis occurred in 5.3% of patients vaccinated against the flu and 7.2% of patients who were given placebo.
Now that the agent shows benefit in mitigating comorbid risks, the expert advocates for more timely diagnoses and treatment initiation.
Investigators observed systolic blood pressure was lower by a rate of 6.9 mm Hg in the intervention group versus the control group.
Paul Feuerstadt, MD: The Future of RBX2660
Fighting for Sight: Geographic Atrophy Drug Development Meets Its Future
Aflibercept Outperforms Bevacizumab at Weaning nAMD Patients Off Treatment
